annual CFF:
$441.45M+$222.99M(+102.07%)Summary
- As of today (July 4, 2025), CLDX annual cash flow from financing activities is $441.45 million, with the most recent change of +$222.99 million (+102.07%) on December 31, 2024.
- During the last 3 years, CLDX annual CFF has risen by +$169.08 million (+62.08%).
- CLDX annual CFF is now at all-time high.
Performance
CLDX Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$202.00K-$184.00K(-47.67%)Summary
- As of today (July 4, 2025), CLDX quarterly cash flow from financing activities is $202.00 thousand, with the most recent change of -$184.00 thousand (-47.67%) on March 31, 2025.
- Over the past year, CLDX quarterly CFF has dropped by -$435.91 million (-99.95%).
- CLDX quarterly CFF is now -99.95% below its all-time high of $436.11 million, reached on March 31, 2024.
Performance
CLDX quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$5.54M-$435.91M(-98.75%)Summary
- As of today (July 4, 2025), CLDX TTM cash flow from financing activities is $5.54 million, with the most recent change of -$435.91 million (-98.75%) on March 31, 2025.
- Over the past year, CLDX TTM CFF has dropped by -$648.34 million (-99.15%).
- CLDX TTM CFF is now -99.16% below its all-time high of $658.44 million, reached on September 30, 2024.
Performance
CLDX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CLDX Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +102.1% | -100.0% | -99.2% |
| 3 y3 years | +62.1% | -33.5% | -98.0% |
| 5 y5 years | +2615.4% | -87.7% | -96.8% |
CLDX Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -100.0% | +184.5% | -99.2% | +123.4% |
| 5 y | 5-year | at high | >+9999.0% | -100.0% | +908.0% | -99.2% | +123.4% |
| alltime | all time | at high | >+9999.0% | -100.0% | +102.2% | -99.2% | +324.7% |
CLDX Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $202.00K(-47.7%) | $5.54M(-98.7%) |
| Dec 2024 | $441.45M(+102.1%) | $386.00K(-68.8%) | $441.45M(-33.0%) |
| Sep 2024 | - | $1.24M(-66.6%) | $658.44M(+0.1%) |
| Jun 2024 | - | $3.71M(-99.1%) | $657.46M(+0.5%) |
| Mar 2024 | - | $436.11M(+100.6%) | $653.88M(+199.3%) |
| Dec 2023 | $218.46M(+5259.6%) | $217.37M(>+9900.0%) | $218.46M(+8712.3%) |
| Sep 2023 | - | $257.00K(+93.2%) | $2.48M(-45.3%) |
| Jun 2023 | - | $133.00K(-80.8%) | $4.53M(+1.4%) |
| Mar 2023 | - | $694.00K(-50.3%) | $4.47M(+9.6%) |
| Dec 2022 | $4.08M(-98.5%) | $1.40M(-39.5%) | $4.08M(+31.2%) |
| Sep 2022 | - | $2.31M(+3147.9%) | $3.11M(-98.9%) |
| Jun 2022 | - | $71.00K(-76.6%) | $272.70M(+0.0%) |
| Mar 2022 | - | $304.00K(-28.6%) | $272.60M(+0.1%) |
| Dec 2021 | $272.37M(+59.1%) | $426.00K(-99.8%) | $272.37M(+0.1%) |
| Sep 2021 | - | $271.90M(<-9900.0%) | $271.99M(+5833.5%) |
| Jun 2021 | - | -$25.00K(-133.8%) | $4.58M(-97.3%) |
| Mar 2021 | - | $74.00K(+68.2%) | $169.66M(-0.9%) |
| Dec 2020 | $171.23M(+953.2%) | $44.00K(-99.0%) | $171.23M(-1.4%) |
| Sep 2020 | - | $4.49M(-97.3%) | $173.60M(+1.2%) |
| Jun 2020 | - | $165.05M(>+9900.0%) | $171.58M(+1149.3%) |
| Mar 2020 | - | $1.64M(-32.4%) | $13.73M(-15.5%) |
| Dec 2019 | $16.26M(-44.8%) | $2.42M(-1.7%) | $16.26M(-6.6%) |
| Sep 2019 | - | $2.46M(-65.8%) | $17.40M(-15.0%) |
| Jun 2019 | - | $7.21M(+73.4%) | $20.48M(-4.9%) |
| Mar 2019 | - | $4.16M(+16.6%) | $21.54M(-26.8%) |
| Dec 2018 | $29.44M(-42.6%) | $3.57M(-35.6%) | $29.44M(-33.6%) |
| Sep 2018 | - | $5.54M(-33.0%) | $44.33M(-11.4%) |
| Jun 2018 | - | $8.27M(-31.4%) | $50.06M(-0.8%) |
| Mar 2018 | - | $12.06M(-34.6%) | $50.46M(-1.6%) |
| Dec 2017 | $51.29M(+254.2%) | $18.46M(+63.8%) | $51.29M(+42.0%) |
| Sep 2017 | - | $11.27M(+30.0%) | $36.12M(+9.0%) |
| Jun 2017 | - | $8.67M(-32.8%) | $33.15M(+22.3%) |
| Mar 2017 | - | $12.90M(+292.7%) | $27.10M(+87.1%) |
| Dec 2016 | $14.48M(-92.5%) | $3.28M(-60.4%) | $14.48M(+25.8%) |
| Sep 2016 | - | $8.30M(+216.7%) | $11.52M(+191.2%) |
| Jun 2016 | - | $2.62M(+835.7%) | $3.95M(+136.5%) |
| Mar 2016 | - | $280.00K(-11.9%) | $1.67M(-99.1%) |
| Dec 2015 | $193.15M(>+9900.0%) | $318.00K(-56.8%) | $193.15M(+0.2%) |
| Sep 2015 | - | $736.00K(+117.8%) | $192.84M(+0.2%) |
| Jun 2015 | - | $338.00K(-99.8%) | $192.41M(+0.1%) |
| Mar 2015 | - | $191.76M(>+9900.0%) | $192.23M(>+9900.0%) |
| Dec 2014 | $1.17M(-99.6%) | $11.00K(-96.4%) | $1.17M(-99.4%) |
| Sep 2014 | - | $304.00K(+97.4%) | $184.71M(-0.2%) |
| Jun 2014 | - | $154.00K(-78.1%) | $185.03M(+5.3%) |
| Mar 2014 | - | $702.00K(-99.6%) | $175.79M(-39.3%) |
| Dec 2013 | $289.60M(+263.1%) | $183.55M(>+9900.0%) | $289.60M(+130.5%) |
| Sep 2013 | - | $622.00K(-106.8%) | $125.62M(-6.7%) |
| Jun 2013 | - | -$9.09M(-107.9%) | $134.58M(-5.5%) |
| Mar 2013 | - | $114.51M(+485.0%) | $142.35M(+78.5%) |
| Dec 2012 | $79.76M(+180.5%) | $19.57M(+104.3%) | $79.76M(+32.2%) |
| Sep 2012 | - | $9.58M(-831.9%) | $60.31M(+18.9%) |
| Jun 2012 | - | -$1.31M(-102.5%) | $50.71M(-42.3%) |
| Mar 2012 | - | $51.91M(>+9900.0%) | $87.90M(+209.1%) |
| Dec 2011 | $28.43M(+162.9%) | $129.00K(-660.9%) | $28.43M(-25.7%) |
| Sep 2011 | - | -$23.00K(-100.1%) | $38.27M(-0.9%) |
| Jun 2011 | - | $35.88M(-575.3%) | $38.62M(+1135.1%) |
| Mar 2011 | - | -$7.55M(-175.8%) | $3.13M(-71.1%) |
| Dec 2010 | $10.82M(-538.8%) | $9.96M(+2882.3%) | $10.82M(-650.2%) |
| Sep 2010 | - | $334.00K(-12.3%) | -$1.97M(-15.7%) |
| Jun 2010 | - | $381.00K(+170.2%) | -$2.33M(+2.1%) |
| Mar 2010 | - | $141.00K(-105.0%) | -$2.28M(-7.4%) |
| Dec 2009 | -$2.46M(-122.6%) | -$2.82M(+9003.2%) | -$2.46M(-730.8%) |
| Sep 2009 | - | -$31.00K(-107.2%) | $390.80K(+17.4%) |
| Jun 2009 | - | $429.00K(-1146.3%) | $332.80K(-96.9%) |
| Mar 2009 | - | -$41.00K(-221.3%) | $10.76M(-1.6%) |
| Dec 2008 | $10.93M(+4033.6%) | $33.80K(-138.0%) | $10.93M(-0.5%) |
| Sep 2008 | - | -$89.00K(-100.8%) | $10.98M(-3.4%) |
| Jun 2008 | - | $10.85M(+8318.5%) | $11.37M(+3435.4%) |
| Mar 2008 | - | $128.90K(+41.8%) | $321.70K(+21.7%) |
| Dec 2007 | $264.30K | $90.90K(-69.9%) | $264.30K(-89.0%) |
| Sep 2007 | - | $302.20K(-250.9%) | $2.41M(+16.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | -$200.30K(-380.1%) | $2.06M(-6.8%) |
| Mar 2007 | - | $71.50K(-96.8%) | $2.21M(+6.6%) |
| Dec 2006 | $2.08M(-1677.5%) | $2.24M(-4894.9%) | $2.08M(-1184.9%) |
| Sep 2006 | - | -$46.70K(-5.5%) | -$191.50K(+4.5%) |
| Jun 2006 | - | -$49.40K(-24.7%) | -$183.30K(+8.6%) |
| Mar 2006 | - | -$65.60K(+120.1%) | -$168.80K(+28.2%) |
| Dec 2005 | -$131.70K(-100.5%) | -$29.80K(-22.6%) | -$131.70K(-106.5%) |
| Sep 2005 | - | -$38.50K(+10.3%) | $2.04M(-3.5%) |
| Jun 2005 | - | -$34.90K(+22.5%) | $2.11M(-2.1%) |
| Mar 2005 | - | -$28.50K(-101.3%) | $2.16M(-91.5%) |
| Dec 2004 | $25.50M(+179.3%) | $2.14M(+5788.4%) | $25.50M(+9.5%) |
| Sep 2004 | - | $36.30K(+249.0%) | $23.29M(-28.4%) |
| Jun 2004 | - | $10.40K(-100.0%) | $32.54M(+0.0%) |
| Mar 2004 | - | $23.31M(<-9900.0%) | $32.52M(+256.2%) |
| Dec 2003 | $9.13M(-9690.1%) | -$64.40K(-100.7%) | $9.13M(+0.3%) |
| Sep 2003 | - | $9.28M(<-9900.0%) | $9.10M(-4270.9%) |
| Jun 2003 | - | -$5400.00(-93.5%) | -$218.20K(+2.5%) |
| Mar 2003 | - | -$82.50K(-11.6%) | -$212.80K(+123.5%) |
| Dec 2002 | -$95.20K(-100.7%) | -$93.30K(+152.2%) | -$95.20K(-100.7%) |
| Sep 2002 | - | -$37.00K(<-9900.0%) | $13.58M(-0.7%) |
| Jun 2002 | - | $0.00(-100.0%) | $13.68M(-1.2%) |
| Mar 2002 | - | $35.10K(-99.7%) | $13.84M(-1.8%) |
| Dec 2001 | $14.09M(-66.4%) | $13.58M(>+9900.0%) | $14.09M(+327.9%) |
| Sep 2001 | - | $58.40K(-63.3%) | $3.29M(-91.4%) |
| Jun 2001 | - | $159.30K(-44.6%) | $38.32M(-0.2%) |
| Mar 2001 | - | $287.80K(-89.7%) | $38.40M(-8.5%) |
| Dec 2000 | $41.96M(+321.6%) | $2.79M(-92.1%) | $41.96M(+7.0%) |
| Sep 2000 | - | $35.08M(>+9900.0%) | $39.22M(+179.4%) |
| Jun 2000 | - | $237.40K(-93.8%) | $14.04M(+1.7%) |
| Mar 2000 | - | $3.85M(+7228.4%) | $13.80M(+38.7%) |
| Dec 1999 | $9.95M(+169.0%) | $52.50K(-99.5%) | $9.95M(+0.5%) |
| Sep 1999 | - | $9.90M(>+9900.0%) | $9.90M(>+9900.0%) |
| Jun 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1999 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 1998 | $3.70M(>+9900.0%) | $0.00(0.0%) | $3.70M(0.0%) |
| Sep 1998 | - | $0.00(0.0%) | $3.70M(0.0%) |
| Jun 1998 | - | $0.00(-100.0%) | $3.70M(0.0%) |
| Mar 1998 | - | $3.70M(>+9900.0%) | $3.70M(>+9900.0%) |
| Dec 1997 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 1997 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Jun 1997 | - | $0.00(0.0%) | $10.00M(-2.0%) |
| Mar 1997 | - | $0.00(0.0%) | $10.20M(0.0%) |
| Dec 1996 | $10.20M(+52.2%) | $0.00(-100.0%) | $10.20M(-38.9%) |
| Sep 1996 | - | $10.00M(+4900.0%) | $16.70M(+142.0%) |
| Jun 1996 | - | $200.00K(>+9900.0%) | $6.90M(+3.0%) |
| Mar 1996 | - | $0.00(-100.0%) | $6.70M(0.0%) |
| Dec 1995 | $6.70M(>+9900.0%) | $6.50M(+3150.0%) | $6.70M(+3250.0%) |
| Sep 1995 | - | $200.00K(>+9900.0%) | $200.00K(>+9900.0%) |
| Jun 1995 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1995 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 1994 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 1994 | - | $0.00(0.0%) | $17.50M(0.0%) |
| Jun 1994 | - | $0.00(0.0%) | $17.50M(-0.6%) |
| Mar 1994 | - | $0.00(-100.0%) | $17.60M(-0.6%) |
| Dec 1993 | $17.70M(+5800.0%) | $17.50M(>+9900.0%) | $17.70M(+8750.0%) |
| Sep 1993 | - | $0.00(-100.0%) | $200.00K(0.0%) |
| Jun 1993 | - | $100.00K(0.0%) | $200.00K(0.0%) |
| Mar 1993 | - | $100.00K(>+9900.0%) | $200.00K(-60.0%) |
| Dec 1992 | $300.00K(-98.4%) | - | - |
| Oct 1992 | - | $0.00(-100.0%) | $500.00K(0.0%) |
| Jul 1992 | - | $100.00K(-80.0%) | $500.00K(-97.3%) |
| Apr 1992 | - | $500.00K(-600.0%) | $18.20M(-1.6%) |
| Apr 1992 | $18.20M(+2175.0%) | - | - |
| Jan 1992 | - | -$100.00K(<-9900.0%) | $18.50M(-0.5%) |
| Oct 1991 | - | $0.00(-100.0%) | $18.60M(0.0%) |
| Jul 1991 | - | $17.80M(+2125.0%) | $18.60M(+2225.0%) |
| Apr 1991 | $800.00K(-76.5%) | $800.00K(>+9900.0%) | $800.00K(>+9900.0%) |
| Jan 1991 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 1990 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jul 1990 | - | $0.00 | $0.00 |
| Apr 1990 | $3.40M | - | - |
FAQ
- What is Celldex Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Celldex Therapeutics?
- What is Celldex Therapeutics annual CFF year-on-year change?
- What is Celldex Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly CFF year-on-year change?
- What is Celldex Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Celldex Therapeutics?
- What is Celldex Therapeutics TTM CFF year-on-year change?
What is Celldex Therapeutics annual cash flow from financing activities?
The current annual CFF of CLDX is $441.45M
What is the all time high annual CFF for Celldex Therapeutics?
Celldex Therapeutics all-time high annual cash flow from financing activities is $441.45M
What is Celldex Therapeutics annual CFF year-on-year change?
Over the past year, CLDX annual cash flow from financing activities has changed by +$222.99M (+102.07%)
What is Celldex Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of CLDX is $202.00K
What is the all time high quarterly CFF for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly cash flow from financing activities is $436.11M
What is Celldex Therapeutics quarterly CFF year-on-year change?
Over the past year, CLDX quarterly cash flow from financing activities has changed by -$435.91M (-99.95%)
What is Celldex Therapeutics TTM cash flow from financing activities?
The current TTM CFF of CLDX is $5.54M
What is the all time high TTM CFF for Celldex Therapeutics?
Celldex Therapeutics all-time high TTM cash flow from financing activities is $658.44M
What is Celldex Therapeutics TTM CFF year-on-year change?
Over the past year, CLDX TTM cash flow from financing activities has changed by -$648.34M (-99.15%)